Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 216

1.

Biodegradable polysilsesquioxane nanoparticles as efficient contrast agents for magnetic resonance imaging.

Vivero-Escoto JL, Rieter WJ, Lau H, Huxford-Phillips RC, Lin W.

Small. 2013 Oct 25;9(20):3523-31. doi: 10.1002/smll.201300198. Epub 2013 Apr 24.

2.

Biocompatible nanotemplate-engineered nanoparticles containing gadolinium: stability and relaxivity of a potential MRI contrast agent.

Zhu D, White RD, Hardy PA, Weerapreeyakul N, Sutthanut K, Jay M.

J Nanosci Nanotechnol. 2006 Apr;6(4):996-1003.

PMID:
16736756
3.

Upconverting rare-earth nanoparticles with a paramagnetic lanthanide complex shell for upconversion fluorescent and magnetic resonance dual-modality imaging.

Wang Y, Ji L, Zhang B, Yin P, Qiu Y, Song D, Zhou J, Li Q.

Nanotechnology. 2013 May 3;24(17):175101. doi: 10.1088/0957-4484/24/17/175101. Epub 2013 Apr 4.

PMID:
23558298
4.

Biodegradable human serum albumin nanoparticles as contrast agents for the detection of hepatocellular carcinoma by magnetic resonance imaging.

Watcharin W, Schmithals C, Pleli T, Köberle V, Korkusuz H, Huebner F, Zeuzem S, Korf HW, Vogl TJ, Rittmeyer C, Terfort A, Piiper A, Gelperina S, Kreuter J.

Eur J Pharm Biopharm. 2014 May;87(1):132-41. doi: 10.1016/j.ejpb.2013.12.010. Epub 2013 Dec 21.

PMID:
24365328
5.

Gd-DTPA L-cystine bisamide copolymers as novel biodegradable macromolecular contrast agents for MR blood pool imaging.

Kaneshiro TL, Ke T, Jeong EK, Parker DL, Lu ZR.

Pharm Res. 2006 Jun;23(6):1285-94. Epub 2006 Jun 1.

PMID:
16729223
6.

Photo-cured PMMA/PEI core/shell nanoparticles surface-modified with Gd-DTPA for T1 MR imaging.

Ratanajanchai M, Lee DH, Sunintaboon P, Yang SG.

J Colloid Interface Sci. 2014 Feb 1;415:70-6. doi: 10.1016/j.jcis.2013.09.049. Epub 2013 Oct 17.

PMID:
24267331
7.

Gadolinium-conjugated PLA-PEG nanoparticles as liver targeted molecular MRI contrast agent.

Chen Z, Yu D, Liu C, Yang X, Zhang N, Ma C, Song J, Lu Z.

J Drug Target. 2011 Sep;19(8):657-65. doi: 10.3109/1061186X.2010.531727. Epub 2010 Nov 23.

PMID:
21091273
8.

Targeted biodegradable dendritic MRI contrast agent for enhanced tumor imaging.

Ye M, Qian Y, Tang J, Hu H, Sui M, Shen Y.

J Control Release. 2013 Aug 10;169(3):239-45. doi: 10.1016/j.jconrel.2013.01.034. Epub 2013 Feb 9.

PMID:
23403397
9.

Bio-inspired, melanin-like nanoparticles as a highly efficient contrast agent for T1-weighted magnetic resonance imaging.

Ju KY, Lee JW, Im GH, Lee S, Pyo J, Park SB, Lee JH, Lee JK.

Biomacromolecules. 2013 Oct 14;14(10):3491-7. doi: 10.1021/bm4008138. Epub 2013 Sep 13.

PMID:
23987128
10.

Rapid synthesis of PEGylated ultrasmall gadolinium oxide nanoparticles for cell labeling and tracking with MRI.

Faucher L, Tremblay M, Lagueux J, Gossuin Y, Fortin MA.

ACS Appl Mater Interfaces. 2012 Sep 26;4(9):4506-15. Epub 2012 Aug 17.

PMID:
22834680
11.

Engineered magnetic hybrid nanoparticles with enhanced relaxivity for tumor imaging.

Aryal S, Key J, Stigliano C, Ananta JS, Zhong M, Decuzzi P.

Biomaterials. 2013 Oct;34(31):7725-32. doi: 10.1016/j.biomaterials.2013.07.003. Epub 2013 Jul 17.

PMID:
23871540
12.

Multifunctional mesoporous silica nanospheres with cleavable Gd(III) chelates as MRI contrast agents: synthesis, characterization, target-specificity, and renal clearance.

Vivero-Escoto JL, Taylor-Pashow KM, Huxford RC, Della Rocca J, Okoruwa C, An H, Lin W, Lin W.

Small. 2011 Dec 16;7(24):3519-28. doi: 10.1002/smll.201100521. Epub 2011 Nov 9.

13.

Gadolinium-containing copolymeric chelates--a new potential MR contrast agent.

Unger EC, Shen D, Wu G, Stewart L, Matsunaga TO, Trouard TP.

MAGMA. 1999 Aug;8(3):154-62.

PMID:
10504042
14.

Structural effect on degradability and in vivo contrast enhancement of polydisulfide Gd(III) complexes as biodegradable macromolecular MRI contrast agents.

Zong Y, Wang X, Jeong EK, Parker DL, Lu ZR.

Magn Reson Imaging. 2009 May;27(4):503-11. doi: 10.1016/j.mri.2008.07.020. Epub 2008 Sep 23.

15.

Novel Gd nanoparticles enhance vascular contrast for high-resolution magnetic resonance imaging.

Bui T, Stevenson J, Hoekman J, Zhang S, Maravilla K, Ho RJ.

PLoS One. 2010 Sep 30;5(9). pii: e13082. doi: 10.1371/journal.pone.0013082.

16.

Nanotemplate-engineered nanoparticles containing gadolinium for magnetic resonance imaging of tumors.

Zhu D, Lu X, Hardy PA, Leggas M, Jay M.

Invest Radiol. 2008 Feb;43(2):129-40. doi: 10.1097/RLI.0b013e31815878dd.

PMID:
18197065
17.

Targeted dual-contrast T1- and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles.

Yang H, Zhuang Y, Sun Y, Dai A, Shi X, Wu D, Li F, Hu H, Yang S.

Biomaterials. 2011 Jul;32(20):4584-93. doi: 10.1016/j.biomaterials.2011.03.018. Epub 2011 Mar 31.

PMID:
21458063
18.

Gadolinium-loaded chitosan nanoparticles as magnetic resonance imaging contrast agents for the diagnosis of tumor.

Zhang L, Liu Y, Yu D, Zhangl N.

J Biomed Nanotechnol. 2013 May;9(5):863-9.

PMID:
23802417
19.

High relaxivities and strong vascular signal enhancement for NaGdF4 nanoparticles designed for dual MR/optical imaging.

Naccache R, Chevallier P, Lagueux J, Gossuin Y, Laurent S, Vander Elst L, Chilian C, Capobianco JA, Fortin MA.

Adv Healthc Mater. 2013 Nov;2(11):1478-88. doi: 10.1002/adhm.201300060. Epub 2013 May 13.

PMID:
23666643
20.

Gold nanoparticles functionalized by gadolinium-DTPA conjugate of cysteine as a multimodal bioimaging agent.

Park JA, Kim HK, Kim JH, Jeong SW, Jung JC, Lee GH, Lee J, Chang Y, Kim TJ.

Bioorg Med Chem Lett. 2010 Apr 1;20(7):2287-91. doi: 10.1016/j.bmcl.2010.02.002. Epub 2010 Feb 6.

PMID:
20188545
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk